ICD-10-CM Billable Code

M10.469

Other secondary gout, unspecified knee

Clinical Classification Guidelines

Medical Intelligence & Overview

Other secondary gout in the knee, classified under ICD-10 code M10.469, refers to a form of gout that develops as a result of another underlying condition. Gout is a type of arthritis caused by the buildup of uric acid crystals in the joints, leading to pain, swelling, and inflammation. When it affects the knee as a secondary condition, it often signifies an underlying health issue contributing to uric acid imbalance and crystal formation. Understanding the causes, symptoms, and treatment options can help manage this condition effectively and improve quality of life.

Causes & Symptoms

Clinical Causes: Chronic kidney disease or renal impairment, which reduces uric acid excretion Use of certain medications like diuretics or aspirin that increase uric acid levels Metabolic disorders, such as obesity or insulin resistance Excessive alcohol consumption that can raise uric acid production High-purine diet rich in red meats, seafood, and organ meats Certain medical conditions, including psoriasis or certain cancers Dehydration leading to increased uric acid concentration in the blood Genetic predisposition affecting uric acid metabolism

Key Symptoms: Intense joint pain, especially in the knee Swelling, redness, and warmth around the knee joint Stiffness and limited movement in the affected knee Sudden flare-ups often occurring at night Tenderness upon touch or movement Possibly fever if the inflammation is severe

Diagnostic & Treatment

Diagnosis Path: Diagnosis often involves a combination of medical history review, physical examination, and laboratory tests. Clinicians may perform joint aspiration to extract synovial fluid from the knee, examining it under a microscope for uric acid crystals. Blood tests measuring serum uric acid levels can support the diagnosis, although levels may sometimes be normal during an acute attack. Imaging studies like X-rays or ultrasound can identify joint damage or uric acid crystal deposits. The combination of symptoms and laboratory findings helps confirm secondary gout.

Treatment Protocols: Management typically focuses on alleviating symptoms, controlling inflammation, and addressing the underlying cause. Common approaches include: - **Medications:** Nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or colchicine to reduce pain and inflammation. - **Urate-lowering therapy:** Medications such as allopurinol or febuxostat may be prescribed to decrease uric acid levels and prevent future attacks. - **Lifestyle changes:** Adopting a low-purine diet, reducing alcohol intake, maintaining a healthy weight, and staying well-hydrated. - **Treating underlying conditions:** Managing kidney disease, metabolic disorders, or medication-related causes that contribute to uric acid buildup. Effective management often requires a combination of these strategies, along with regular monitoring and follow-up with healthcare professionals.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M10.469 a billable ICD-10 code?
Yes, M10.469 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M10.469?
Clinical documentation must specify the nature of Other secondary gout, unspecified knee and any associated comorbidities for accurate reporting.

Cite this Clinical Reference